NovoCure Limited
NVCR
$15.21
$3.2827.49%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/30/2026
-
MarketBeat
4/30/2026
-
Nasdaq News: Markets
4/30/2026
-
Fool.com Headlines
4/30/2026
-
Seeking Alpha - Healthcare
4/30/2026
-
SeekingAlpha
4/30/2026
-
Seeking Alpha: Transcripts
4/30/2026
-
TipRanks Financial Blog
4/30/2026
-
Investor's Business Daily
4/30/2026
-
MarketBeat
4/30/2026
-
Seeking Alpha - Healthcare
4/30/2026
-
Benzinga
4/30/2026
-
MarketBeat
4/30/2026
-
Yahoo! Finance: News
4/30/2026
-
TipRanks Financial Blog
4/30/2026
-
TipRanks Financial Blog
4/30/2026
-
Benzinga
4/30/2026
-
Zacks Investment Research
4/30/2026
-
Zacks Investment Research
4/30/2026
-
TipRanks Financial Blog
4/30/2026
-
Business Wire
4/30/2026
-
Tickeron - Stocks
4/30/2026
-
Tickeron - Stocks
4/25/2026
-
MarketBeat
4/23/2026
-
MarketBeat
4/17/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Apr 20 and 24 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
Address
Neuhofstrasse 21
Baar, 6340
Baar, 6340
Country
Year Founded
Business Description
Sector
--
Industry
--
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the...
more